Structured Review

Abcam goat polyclonal anti cdcp1 ab1377
<t>CDCP1</t> protein expression in colon cancer cell lines and modulation of adhesion and motility. A) Cell-surface expression of CDCP1 was measured by flow cytometry using monoclonal mouse anti-CDCP1 clone CUB1. Bound primary antibody was detected with Alexa488-conjugated goat anti-mouse IgG. Standard error bars are shown. n ≥3, except HaCaT where n =2. Cell lines are indicated that showed significantly different CDCP1 cell-surface expression from HaCaT as determined by independent sample 2-tailed t-tests not assuming equal variance. GMF CDCP1, geometric mean fluorescence of bound anti-CDCP1. *p ≤0.05; *** = p ≤0.001. B) Western blot for CDCP1. Total cell protein (40 μg) was separated by SDS-PAGE, transferred to PVDF and CDCP1 detected using 1 μg/ml goat polyclonal antibody anti-CDCP1 antibody <t>(ab1377).</t> The membrane was re-probed for GAPDH to assess protein loading. The image is representative of three blots from independent lysates. C) Binding of stable CDCP1-expressing Colo320 (Colo320-CDCP1) and control Colo320 (Colo320-pcDNA3) cells to control or 10 μg/ml Matrigel coated tissue culture plates. The Colo320 cell-substratum assays were repeated four times. *** = p ≤0.001. D) Adhesion of SW480 cells to control or Matrigel-coated tissue culture plates following reduction of CDCP1 by RNA interference. The experiment was repeated three times. Control, cells transfected with control siRNA; CDCP1, cells transfected with CDCP1 siRNA oligo 2 (see Additional file : Figure S2). E) Motility of SW480 cells through an 8 μm pore membrane towards serum following reduction of CDCP1 by RNA interference. This was measured in arbitrary units (AU) at 60 h after siRNA transfection using the xCELLigence system Real-Time Cell Analyzer Dual Plate (RTCA DP, Roche). UT, untransfected cells; mock, cells treated with Lipofectamine 2000 only; Control siRNA, cells transfected with CDCP1 siRNA oligo 2. See Additional file : Figure S3 for a more extensive kinetic analysis.
Goat Polyclonal Anti Cdcp1 Ab1377, supplied by Abcam, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/goat polyclonal anti cdcp1 ab1377/product/Abcam
Average 86 stars, based on 1 article reviews
Price from $9.99 to $1999.99
goat polyclonal anti cdcp1 ab1377 - by Bioz Stars, 2024-07
86/100 stars

Images

1) Product Images from "CUB Domain Containing Protein 1 (CDCP1) modulates adhesion and motility in colon cancer cells"

Article Title: CUB Domain Containing Protein 1 (CDCP1) modulates adhesion and motility in colon cancer cells

Journal: BMC Cancer

doi: 10.1186/1471-2407-14-754

CDCP1 protein expression in colon cancer cell lines and modulation of adhesion and motility. A) Cell-surface expression of CDCP1 was measured by flow cytometry using monoclonal mouse anti-CDCP1 clone CUB1. Bound primary antibody was detected with Alexa488-conjugated goat anti-mouse IgG. Standard error bars are shown. n ≥3, except HaCaT where n =2. Cell lines are indicated that showed significantly different CDCP1 cell-surface expression from HaCaT as determined by independent sample 2-tailed t-tests not assuming equal variance. GMF CDCP1, geometric mean fluorescence of bound anti-CDCP1. *p ≤0.05; *** = p ≤0.001. B) Western blot for CDCP1. Total cell protein (40 μg) was separated by SDS-PAGE, transferred to PVDF and CDCP1 detected using 1 μg/ml goat polyclonal antibody anti-CDCP1 antibody (ab1377). The membrane was re-probed for GAPDH to assess protein loading. The image is representative of three blots from independent lysates. C) Binding of stable CDCP1-expressing Colo320 (Colo320-CDCP1) and control Colo320 (Colo320-pcDNA3) cells to control or 10 μg/ml Matrigel coated tissue culture plates. The Colo320 cell-substratum assays were repeated four times. *** = p ≤0.001. D) Adhesion of SW480 cells to control or Matrigel-coated tissue culture plates following reduction of CDCP1 by RNA interference. The experiment was repeated three times. Control, cells transfected with control siRNA; CDCP1, cells transfected with CDCP1 siRNA oligo 2 (see Additional file : Figure S2). E) Motility of SW480 cells through an 8 μm pore membrane towards serum following reduction of CDCP1 by RNA interference. This was measured in arbitrary units (AU) at 60 h after siRNA transfection using the xCELLigence system Real-Time Cell Analyzer Dual Plate (RTCA DP, Roche). UT, untransfected cells; mock, cells treated with Lipofectamine 2000 only; Control siRNA, cells transfected with CDCP1 siRNA oligo 2. See Additional file : Figure S3 for a more extensive kinetic analysis.
Figure Legend Snippet: CDCP1 protein expression in colon cancer cell lines and modulation of adhesion and motility. A) Cell-surface expression of CDCP1 was measured by flow cytometry using monoclonal mouse anti-CDCP1 clone CUB1. Bound primary antibody was detected with Alexa488-conjugated goat anti-mouse IgG. Standard error bars are shown. n ≥3, except HaCaT where n =2. Cell lines are indicated that showed significantly different CDCP1 cell-surface expression from HaCaT as determined by independent sample 2-tailed t-tests not assuming equal variance. GMF CDCP1, geometric mean fluorescence of bound anti-CDCP1. *p ≤0.05; *** = p ≤0.001. B) Western blot for CDCP1. Total cell protein (40 μg) was separated by SDS-PAGE, transferred to PVDF and CDCP1 detected using 1 μg/ml goat polyclonal antibody anti-CDCP1 antibody (ab1377). The membrane was re-probed for GAPDH to assess protein loading. The image is representative of three blots from independent lysates. C) Binding of stable CDCP1-expressing Colo320 (Colo320-CDCP1) and control Colo320 (Colo320-pcDNA3) cells to control or 10 μg/ml Matrigel coated tissue culture plates. The Colo320 cell-substratum assays were repeated four times. *** = p ≤0.001. D) Adhesion of SW480 cells to control or Matrigel-coated tissue culture plates following reduction of CDCP1 by RNA interference. The experiment was repeated three times. Control, cells transfected with control siRNA; CDCP1, cells transfected with CDCP1 siRNA oligo 2 (see Additional file : Figure S2). E) Motility of SW480 cells through an 8 μm pore membrane towards serum following reduction of CDCP1 by RNA interference. This was measured in arbitrary units (AU) at 60 h after siRNA transfection using the xCELLigence system Real-Time Cell Analyzer Dual Plate (RTCA DP, Roche). UT, untransfected cells; mock, cells treated with Lipofectamine 2000 only; Control siRNA, cells transfected with CDCP1 siRNA oligo 2. See Additional file : Figure S3 for a more extensive kinetic analysis.

Techniques Used: Expressing, Flow Cytometry, Fluorescence, Western Blot, SDS Page, Binding Assay, Transfection

CDCP1 and CD9 expression in colon cancer cell lines. A) Cell-surface CD9 expression was measured by flow cytometry using monoclonal mouse anti-CD9 clone ALB6. The primary antibody was detected with Alexa488-conjugated goat anti-mouse IgG. Ten thousand cells were gated per sample. Standard error bars are shown. GMF, geometric mean fluorescence. B) Western blot analysis of CD9 expression. Total cell protein (40 μg) in RIPA buffer was separated by SDS-PAGE, transferred to PVDF and CD9 detected using 2 μg/ml mouse monoclonal antibody clone 602–29. Subsequently the PVDF membrane was stripped and re-probed for GAPDH to assess loading. The image is representative of three blots. Arrows indicate the locations of the CD9 species termed p27 and p25. C) An XY plot of the average CDCP1 and CD9 cell surface expression per cell line. A line of best fit was generated by linear regression. There is a significant positive correlation by bivariate Pearson correlation analysis. *p =0.044. GMF, geometric mean fluorescence. D) CDCP1 and CD9 mRNA expression determined by microarray (Robust multi-array average (RMA)) from 47 colon cancer cell lines was downloaded from the Cancer Cell Line Encyclopedia . An XY plot was generated. The cell lines that were experimentally tested for cell-surface CDCP1 and CD9 protein expression are highlighted in red. A line of best fit was generated by linear regression. There is a highly significant positive correlation as reported by a bivariate Pearson correlation analysis. ***p < 0.001.
Figure Legend Snippet: CDCP1 and CD9 expression in colon cancer cell lines. A) Cell-surface CD9 expression was measured by flow cytometry using monoclonal mouse anti-CD9 clone ALB6. The primary antibody was detected with Alexa488-conjugated goat anti-mouse IgG. Ten thousand cells were gated per sample. Standard error bars are shown. GMF, geometric mean fluorescence. B) Western blot analysis of CD9 expression. Total cell protein (40 μg) in RIPA buffer was separated by SDS-PAGE, transferred to PVDF and CD9 detected using 2 μg/ml mouse monoclonal antibody clone 602–29. Subsequently the PVDF membrane was stripped and re-probed for GAPDH to assess loading. The image is representative of three blots. Arrows indicate the locations of the CD9 species termed p27 and p25. C) An XY plot of the average CDCP1 and CD9 cell surface expression per cell line. A line of best fit was generated by linear regression. There is a significant positive correlation by bivariate Pearson correlation analysis. *p =0.044. GMF, geometric mean fluorescence. D) CDCP1 and CD9 mRNA expression determined by microarray (Robust multi-array average (RMA)) from 47 colon cancer cell lines was downloaded from the Cancer Cell Line Encyclopedia . An XY plot was generated. The cell lines that were experimentally tested for cell-surface CDCP1 and CD9 protein expression are highlighted in red. A line of best fit was generated by linear regression. There is a highly significant positive correlation as reported by a bivariate Pearson correlation analysis. ***p < 0.001.

Techniques Used: Expressing, Flow Cytometry, Fluorescence, Western Blot, SDS Page, Generated, Microarray

Analysis of CDCP1 and CD9 in detergent-resistant membrane (DRM) fractions of HT-29 colon cancer cells. HT-29 cells were plated at 3.8 × 10 6 cells per T175 flask and grown to confluence. The cells were scraped into MBS containing either 0.5% Triton-X100, Brij58 or Brij97 on ice. The lysates were fractionated by sucrose density gradient centrifugation as described in Materials and Methods. Eleven 0.5 ml fractions were collected, with fraction 1 being the top and fraction 11 the bottom of the gradient. The fractions were analysed by Western blotting using the following antibodies (final concentrations in parentheses): CDCP1 (1 μg/ml goat ab1377), CD9 (2 μg/ml mouse monoclonal 602–29), TfR (100 ng/ml mouse monoclonal H68.4 (13–6800)), Flotillin-1 (50 ng/ml). A, B: Triton X-100 extraction; C, D: Brij58 extraction; E, F: Brij97 extraction. B, D, F: Quantitation of the Western blots shown in panels A,C and E respectively using Advanced Image Data Analyzer (AIDA) software.
Figure Legend Snippet: Analysis of CDCP1 and CD9 in detergent-resistant membrane (DRM) fractions of HT-29 colon cancer cells. HT-29 cells were plated at 3.8 × 10 6 cells per T175 flask and grown to confluence. The cells were scraped into MBS containing either 0.5% Triton-X100, Brij58 or Brij97 on ice. The lysates were fractionated by sucrose density gradient centrifugation as described in Materials and Methods. Eleven 0.5 ml fractions were collected, with fraction 1 being the top and fraction 11 the bottom of the gradient. The fractions were analysed by Western blotting using the following antibodies (final concentrations in parentheses): CDCP1 (1 μg/ml goat ab1377), CD9 (2 μg/ml mouse monoclonal 602–29), TfR (100 ng/ml mouse monoclonal H68.4 (13–6800)), Flotillin-1 (50 ng/ml). A, B: Triton X-100 extraction; C, D: Brij58 extraction; E, F: Brij97 extraction. B, D, F: Quantitation of the Western blots shown in panels A,C and E respectively using Advanced Image Data Analyzer (AIDA) software.

Techniques Used: Gradient Centrifugation, Western Blot, Quantitation Assay, Software

Co-immunoprecipitation of CDCP1 and CD9. SW480 cells were lysed in 1% (w/v) Brij97, 10 mM Tris–HCl (pH 7.4), 150 mM NaCl, 1 mM CaCl 2 , 1 mM MgCl 2 . A. Immunoprecipitation from whole cell extracts of SW480 cells was performed using 5 μg of ALB6 anti-CD9 monoclonal antibody (lane 6) or isotype-matched control antibody (lane 5). Immunoprecipitates were analysed by Western blotting with antibodies against either CDCP1 (ab1377), top panel; EpCAM (ab32392), middle panel or CD9 (602.29), lower panel. Further controls for the specificity of immunoprecipitation and Western blotting are: lane 1: 15 μg whole cell extract, lanes 2 and 3: 5 μg of isotype-control antibody and anti-CD9 antibody respectively; lane 4: SW480 proteins bound to protein G beads. B. Densitometric analysis of the Western blot for CDCP1. A portion of the blot corresponding to the CDCP1 p135 region was analysed in the tracks generated by immunoprecipitation with the control (red) and anti-CD9 (green) antibodies using AIDA software.
Figure Legend Snippet: Co-immunoprecipitation of CDCP1 and CD9. SW480 cells were lysed in 1% (w/v) Brij97, 10 mM Tris–HCl (pH 7.4), 150 mM NaCl, 1 mM CaCl 2 , 1 mM MgCl 2 . A. Immunoprecipitation from whole cell extracts of SW480 cells was performed using 5 μg of ALB6 anti-CD9 monoclonal antibody (lane 6) or isotype-matched control antibody (lane 5). Immunoprecipitates were analysed by Western blotting with antibodies against either CDCP1 (ab1377), top panel; EpCAM (ab32392), middle panel or CD9 (602.29), lower panel. Further controls for the specificity of immunoprecipitation and Western blotting are: lane 1: 15 μg whole cell extract, lanes 2 and 3: 5 μg of isotype-control antibody and anti-CD9 antibody respectively; lane 4: SW480 proteins bound to protein G beads. B. Densitometric analysis of the Western blot for CDCP1. A portion of the blot corresponding to the CDCP1 p135 region was analysed in the tracks generated by immunoprecipitation with the control (red) and anti-CD9 (green) antibodies using AIDA software.

Techniques Used: Immunoprecipitation, Western Blot, Generated, Software


Structured Review

Abcam goat anti cdcp1 antibody ab1377
Goat Anti Cdcp1 Antibody Ab1377, supplied by Abcam, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/goat anti cdcp1 antibody ab1377/product/Abcam
Average 86 stars, based on 1 article reviews
Price from $9.99 to $1999.99
goat anti cdcp1 antibody ab1377 - by Bioz Stars, 2024-07
86/100 stars

Images


Structured Review

Abcam anti cdcp1 antibody ab1377
Anti Cdcp1 Antibody Ab1377, supplied by Abcam, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti cdcp1 antibody ab1377/product/Abcam
Average 86 stars, based on 1 article reviews
Price from $9.99 to $1999.99
anti cdcp1 antibody ab1377 - by Bioz Stars, 2024-07
86/100 stars

Images


Structured Review

Abcam anti cdcp1 antibody ab1377
TABLE 1.
Anti Cdcp1 Antibody Ab1377, supplied by Abcam, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti cdcp1 antibody ab1377/product/Abcam
Average 86 stars, based on 1 article reviews
Price from $9.99 to $1999.99
anti cdcp1 antibody ab1377 - by Bioz Stars, 2024-07
86/100 stars

Images

1) Product Images from "CUB Domain-Containing Protein 1 Is a Novel Regulator of Anoikis Resistance in Lung Adenocarcinoma"

Article Title: CUB Domain-Containing Protein 1 Is a Novel Regulator of Anoikis Resistance in Lung Adenocarcinoma

Journal:

doi: 10.1128/MCB.01246-07

TABLE 1.
Figure Legend Snippet: TABLE 1.

Techniques Used:


Structured Review

Abcam anti cdcp1 antibody ab1377
TABLE 1.
Anti Cdcp1 Antibody Ab1377, supplied by Abcam, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti cdcp1 antibody ab1377/product/Abcam
Average 86 stars, based on 1 article reviews
Price from $9.99 to $1999.99
anti cdcp1 antibody ab1377 - by Bioz Stars, 2024-07
86/100 stars

Images

1) Product Images from "CUB Domain-Containing Protein 1 Is a Novel Regulator of Anoikis Resistance in Lung Adenocarcinoma "

Article Title: CUB Domain-Containing Protein 1 Is a Novel Regulator of Anoikis Resistance in Lung Adenocarcinoma

Journal:

doi: 10.1128/MCB.01246-07

TABLE 1.
Figure Legend Snippet: TABLE 1.

Techniques Used:

Similar Products

  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 86
    Abcam goat polyclonal anti cdcp1 ab1377
    <t>CDCP1</t> protein expression in colon cancer cell lines and modulation of adhesion and motility. A) Cell-surface expression of CDCP1 was measured by flow cytometry using monoclonal mouse anti-CDCP1 clone CUB1. Bound primary antibody was detected with Alexa488-conjugated goat anti-mouse IgG. Standard error bars are shown. n ≥3, except HaCaT where n =2. Cell lines are indicated that showed significantly different CDCP1 cell-surface expression from HaCaT as determined by independent sample 2-tailed t-tests not assuming equal variance. GMF CDCP1, geometric mean fluorescence of bound anti-CDCP1. *p ≤0.05; *** = p ≤0.001. B) Western blot for CDCP1. Total cell protein (40 μg) was separated by SDS-PAGE, transferred to PVDF and CDCP1 detected using 1 μg/ml goat polyclonal antibody anti-CDCP1 antibody <t>(ab1377).</t> The membrane was re-probed for GAPDH to assess protein loading. The image is representative of three blots from independent lysates. C) Binding of stable CDCP1-expressing Colo320 (Colo320-CDCP1) and control Colo320 (Colo320-pcDNA3) cells to control or 10 μg/ml Matrigel coated tissue culture plates. The Colo320 cell-substratum assays were repeated four times. *** = p ≤0.001. D) Adhesion of SW480 cells to control or Matrigel-coated tissue culture plates following reduction of CDCP1 by RNA interference. The experiment was repeated three times. Control, cells transfected with control siRNA; CDCP1, cells transfected with CDCP1 siRNA oligo 2 (see Additional file : Figure S2). E) Motility of SW480 cells through an 8 μm pore membrane towards serum following reduction of CDCP1 by RNA interference. This was measured in arbitrary units (AU) at 60 h after siRNA transfection using the xCELLigence system Real-Time Cell Analyzer Dual Plate (RTCA DP, Roche). UT, untransfected cells; mock, cells treated with Lipofectamine 2000 only; Control siRNA, cells transfected with CDCP1 siRNA oligo 2. See Additional file : Figure S3 for a more extensive kinetic analysis.
    Goat Polyclonal Anti Cdcp1 Ab1377, supplied by Abcam, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/goat polyclonal anti cdcp1 ab1377/product/Abcam
    Average 86 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    goat polyclonal anti cdcp1 ab1377 - by Bioz Stars, 2024-07
    86/100 stars
      Buy from Supplier

    86
    Abcam goat anti cdcp1 antibody ab1377
    <t>CDCP1</t> protein expression in colon cancer cell lines and modulation of adhesion and motility. A) Cell-surface expression of CDCP1 was measured by flow cytometry using monoclonal mouse anti-CDCP1 clone CUB1. Bound primary antibody was detected with Alexa488-conjugated goat anti-mouse IgG. Standard error bars are shown. n ≥3, except HaCaT where n =2. Cell lines are indicated that showed significantly different CDCP1 cell-surface expression from HaCaT as determined by independent sample 2-tailed t-tests not assuming equal variance. GMF CDCP1, geometric mean fluorescence of bound anti-CDCP1. *p ≤0.05; *** = p ≤0.001. B) Western blot for CDCP1. Total cell protein (40 μg) was separated by SDS-PAGE, transferred to PVDF and CDCP1 detected using 1 μg/ml goat polyclonal antibody anti-CDCP1 antibody <t>(ab1377).</t> The membrane was re-probed for GAPDH to assess protein loading. The image is representative of three blots from independent lysates. C) Binding of stable CDCP1-expressing Colo320 (Colo320-CDCP1) and control Colo320 (Colo320-pcDNA3) cells to control or 10 μg/ml Matrigel coated tissue culture plates. The Colo320 cell-substratum assays were repeated four times. *** = p ≤0.001. D) Adhesion of SW480 cells to control or Matrigel-coated tissue culture plates following reduction of CDCP1 by RNA interference. The experiment was repeated three times. Control, cells transfected with control siRNA; CDCP1, cells transfected with CDCP1 siRNA oligo 2 (see Additional file : Figure S2). E) Motility of SW480 cells through an 8 μm pore membrane towards serum following reduction of CDCP1 by RNA interference. This was measured in arbitrary units (AU) at 60 h after siRNA transfection using the xCELLigence system Real-Time Cell Analyzer Dual Plate (RTCA DP, Roche). UT, untransfected cells; mock, cells treated with Lipofectamine 2000 only; Control siRNA, cells transfected with CDCP1 siRNA oligo 2. See Additional file : Figure S3 for a more extensive kinetic analysis.
    Goat Anti Cdcp1 Antibody Ab1377, supplied by Abcam, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/goat anti cdcp1 antibody ab1377/product/Abcam
    Average 86 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    goat anti cdcp1 antibody ab1377 - by Bioz Stars, 2024-07
    86/100 stars
      Buy from Supplier

    86
    Abcam anti cdcp1 antibody ab1377
    <t>CDCP1</t> protein expression in colon cancer cell lines and modulation of adhesion and motility. A) Cell-surface expression of CDCP1 was measured by flow cytometry using monoclonal mouse anti-CDCP1 clone CUB1. Bound primary antibody was detected with Alexa488-conjugated goat anti-mouse IgG. Standard error bars are shown. n ≥3, except HaCaT where n =2. Cell lines are indicated that showed significantly different CDCP1 cell-surface expression from HaCaT as determined by independent sample 2-tailed t-tests not assuming equal variance. GMF CDCP1, geometric mean fluorescence of bound anti-CDCP1. *p ≤0.05; *** = p ≤0.001. B) Western blot for CDCP1. Total cell protein (40 μg) was separated by SDS-PAGE, transferred to PVDF and CDCP1 detected using 1 μg/ml goat polyclonal antibody anti-CDCP1 antibody <t>(ab1377).</t> The membrane was re-probed for GAPDH to assess protein loading. The image is representative of three blots from independent lysates. C) Binding of stable CDCP1-expressing Colo320 (Colo320-CDCP1) and control Colo320 (Colo320-pcDNA3) cells to control or 10 μg/ml Matrigel coated tissue culture plates. The Colo320 cell-substratum assays were repeated four times. *** = p ≤0.001. D) Adhesion of SW480 cells to control or Matrigel-coated tissue culture plates following reduction of CDCP1 by RNA interference. The experiment was repeated three times. Control, cells transfected with control siRNA; CDCP1, cells transfected with CDCP1 siRNA oligo 2 (see Additional file : Figure S2). E) Motility of SW480 cells through an 8 μm pore membrane towards serum following reduction of CDCP1 by RNA interference. This was measured in arbitrary units (AU) at 60 h after siRNA transfection using the xCELLigence system Real-Time Cell Analyzer Dual Plate (RTCA DP, Roche). UT, untransfected cells; mock, cells treated with Lipofectamine 2000 only; Control siRNA, cells transfected with CDCP1 siRNA oligo 2. See Additional file : Figure S3 for a more extensive kinetic analysis.
    Anti Cdcp1 Antibody Ab1377, supplied by Abcam, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti cdcp1 antibody ab1377/product/Abcam
    Average 86 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    anti cdcp1 antibody ab1377 - by Bioz Stars, 2024-07
    86/100 stars
      Buy from Supplier

    Image Search Results


    CDCP1 protein expression in colon cancer cell lines and modulation of adhesion and motility. A) Cell-surface expression of CDCP1 was measured by flow cytometry using monoclonal mouse anti-CDCP1 clone CUB1. Bound primary antibody was detected with Alexa488-conjugated goat anti-mouse IgG. Standard error bars are shown. n ≥3, except HaCaT where n =2. Cell lines are indicated that showed significantly different CDCP1 cell-surface expression from HaCaT as determined by independent sample 2-tailed t-tests not assuming equal variance. GMF CDCP1, geometric mean fluorescence of bound anti-CDCP1. *p ≤0.05; *** = p ≤0.001. B) Western blot for CDCP1. Total cell protein (40 μg) was separated by SDS-PAGE, transferred to PVDF and CDCP1 detected using 1 μg/ml goat polyclonal antibody anti-CDCP1 antibody (ab1377). The membrane was re-probed for GAPDH to assess protein loading. The image is representative of three blots from independent lysates. C) Binding of stable CDCP1-expressing Colo320 (Colo320-CDCP1) and control Colo320 (Colo320-pcDNA3) cells to control or 10 μg/ml Matrigel coated tissue culture plates. The Colo320 cell-substratum assays were repeated four times. *** = p ≤0.001. D) Adhesion of SW480 cells to control or Matrigel-coated tissue culture plates following reduction of CDCP1 by RNA interference. The experiment was repeated three times. Control, cells transfected with control siRNA; CDCP1, cells transfected with CDCP1 siRNA oligo 2 (see Additional file : Figure S2). E) Motility of SW480 cells through an 8 μm pore membrane towards serum following reduction of CDCP1 by RNA interference. This was measured in arbitrary units (AU) at 60 h after siRNA transfection using the xCELLigence system Real-Time Cell Analyzer Dual Plate (RTCA DP, Roche). UT, untransfected cells; mock, cells treated with Lipofectamine 2000 only; Control siRNA, cells transfected with CDCP1 siRNA oligo 2. See Additional file : Figure S3 for a more extensive kinetic analysis.

    Journal: BMC Cancer

    Article Title: CUB Domain Containing Protein 1 (CDCP1) modulates adhesion and motility in colon cancer cells

    doi: 10.1186/1471-2407-14-754

    Figure Lengend Snippet: CDCP1 protein expression in colon cancer cell lines and modulation of adhesion and motility. A) Cell-surface expression of CDCP1 was measured by flow cytometry using monoclonal mouse anti-CDCP1 clone CUB1. Bound primary antibody was detected with Alexa488-conjugated goat anti-mouse IgG. Standard error bars are shown. n ≥3, except HaCaT where n =2. Cell lines are indicated that showed significantly different CDCP1 cell-surface expression from HaCaT as determined by independent sample 2-tailed t-tests not assuming equal variance. GMF CDCP1, geometric mean fluorescence of bound anti-CDCP1. *p ≤0.05; *** = p ≤0.001. B) Western blot for CDCP1. Total cell protein (40 μg) was separated by SDS-PAGE, transferred to PVDF and CDCP1 detected using 1 μg/ml goat polyclonal antibody anti-CDCP1 antibody (ab1377). The membrane was re-probed for GAPDH to assess protein loading. The image is representative of three blots from independent lysates. C) Binding of stable CDCP1-expressing Colo320 (Colo320-CDCP1) and control Colo320 (Colo320-pcDNA3) cells to control or 10 μg/ml Matrigel coated tissue culture plates. The Colo320 cell-substratum assays were repeated four times. *** = p ≤0.001. D) Adhesion of SW480 cells to control or Matrigel-coated tissue culture plates following reduction of CDCP1 by RNA interference. The experiment was repeated three times. Control, cells transfected with control siRNA; CDCP1, cells transfected with CDCP1 siRNA oligo 2 (see Additional file : Figure S2). E) Motility of SW480 cells through an 8 μm pore membrane towards serum following reduction of CDCP1 by RNA interference. This was measured in arbitrary units (AU) at 60 h after siRNA transfection using the xCELLigence system Real-Time Cell Analyzer Dual Plate (RTCA DP, Roche). UT, untransfected cells; mock, cells treated with Lipofectamine 2000 only; Control siRNA, cells transfected with CDCP1 siRNA oligo 2. See Additional file : Figure S3 for a more extensive kinetic analysis.

    Article Snippet: Goat polyclonal anti-CDCP1 (Ab1377) was from Abcam (Cambridge, U.K.).

    Techniques: Expressing, Flow Cytometry, Fluorescence, Western Blot, SDS Page, Binding Assay, Transfection

    CDCP1 and CD9 expression in colon cancer cell lines. A) Cell-surface CD9 expression was measured by flow cytometry using monoclonal mouse anti-CD9 clone ALB6. The primary antibody was detected with Alexa488-conjugated goat anti-mouse IgG. Ten thousand cells were gated per sample. Standard error bars are shown. GMF, geometric mean fluorescence. B) Western blot analysis of CD9 expression. Total cell protein (40 μg) in RIPA buffer was separated by SDS-PAGE, transferred to PVDF and CD9 detected using 2 μg/ml mouse monoclonal antibody clone 602–29. Subsequently the PVDF membrane was stripped and re-probed for GAPDH to assess loading. The image is representative of three blots. Arrows indicate the locations of the CD9 species termed p27 and p25. C) An XY plot of the average CDCP1 and CD9 cell surface expression per cell line. A line of best fit was generated by linear regression. There is a significant positive correlation by bivariate Pearson correlation analysis. *p =0.044. GMF, geometric mean fluorescence. D) CDCP1 and CD9 mRNA expression determined by microarray (Robust multi-array average (RMA)) from 47 colon cancer cell lines was downloaded from the Cancer Cell Line Encyclopedia . An XY plot was generated. The cell lines that were experimentally tested for cell-surface CDCP1 and CD9 protein expression are highlighted in red. A line of best fit was generated by linear regression. There is a highly significant positive correlation as reported by a bivariate Pearson correlation analysis. ***p < 0.001.

    Journal: BMC Cancer

    Article Title: CUB Domain Containing Protein 1 (CDCP1) modulates adhesion and motility in colon cancer cells

    doi: 10.1186/1471-2407-14-754

    Figure Lengend Snippet: CDCP1 and CD9 expression in colon cancer cell lines. A) Cell-surface CD9 expression was measured by flow cytometry using monoclonal mouse anti-CD9 clone ALB6. The primary antibody was detected with Alexa488-conjugated goat anti-mouse IgG. Ten thousand cells were gated per sample. Standard error bars are shown. GMF, geometric mean fluorescence. B) Western blot analysis of CD9 expression. Total cell protein (40 μg) in RIPA buffer was separated by SDS-PAGE, transferred to PVDF and CD9 detected using 2 μg/ml mouse monoclonal antibody clone 602–29. Subsequently the PVDF membrane was stripped and re-probed for GAPDH to assess loading. The image is representative of three blots. Arrows indicate the locations of the CD9 species termed p27 and p25. C) An XY plot of the average CDCP1 and CD9 cell surface expression per cell line. A line of best fit was generated by linear regression. There is a significant positive correlation by bivariate Pearson correlation analysis. *p =0.044. GMF, geometric mean fluorescence. D) CDCP1 and CD9 mRNA expression determined by microarray (Robust multi-array average (RMA)) from 47 colon cancer cell lines was downloaded from the Cancer Cell Line Encyclopedia . An XY plot was generated. The cell lines that were experimentally tested for cell-surface CDCP1 and CD9 protein expression are highlighted in red. A line of best fit was generated by linear regression. There is a highly significant positive correlation as reported by a bivariate Pearson correlation analysis. ***p < 0.001.

    Article Snippet: Goat polyclonal anti-CDCP1 (Ab1377) was from Abcam (Cambridge, U.K.).

    Techniques: Expressing, Flow Cytometry, Fluorescence, Western Blot, SDS Page, Generated, Microarray

    Analysis of CDCP1 and CD9 in detergent-resistant membrane (DRM) fractions of HT-29 colon cancer cells. HT-29 cells were plated at 3.8 × 10 6 cells per T175 flask and grown to confluence. The cells were scraped into MBS containing either 0.5% Triton-X100, Brij58 or Brij97 on ice. The lysates were fractionated by sucrose density gradient centrifugation as described in Materials and Methods. Eleven 0.5 ml fractions were collected, with fraction 1 being the top and fraction 11 the bottom of the gradient. The fractions were analysed by Western blotting using the following antibodies (final concentrations in parentheses): CDCP1 (1 μg/ml goat ab1377), CD9 (2 μg/ml mouse monoclonal 602–29), TfR (100 ng/ml mouse monoclonal H68.4 (13–6800)), Flotillin-1 (50 ng/ml). A, B: Triton X-100 extraction; C, D: Brij58 extraction; E, F: Brij97 extraction. B, D, F: Quantitation of the Western blots shown in panels A,C and E respectively using Advanced Image Data Analyzer (AIDA) software.

    Journal: BMC Cancer

    Article Title: CUB Domain Containing Protein 1 (CDCP1) modulates adhesion and motility in colon cancer cells

    doi: 10.1186/1471-2407-14-754

    Figure Lengend Snippet: Analysis of CDCP1 and CD9 in detergent-resistant membrane (DRM) fractions of HT-29 colon cancer cells. HT-29 cells were plated at 3.8 × 10 6 cells per T175 flask and grown to confluence. The cells were scraped into MBS containing either 0.5% Triton-X100, Brij58 or Brij97 on ice. The lysates were fractionated by sucrose density gradient centrifugation as described in Materials and Methods. Eleven 0.5 ml fractions were collected, with fraction 1 being the top and fraction 11 the bottom of the gradient. The fractions were analysed by Western blotting using the following antibodies (final concentrations in parentheses): CDCP1 (1 μg/ml goat ab1377), CD9 (2 μg/ml mouse monoclonal 602–29), TfR (100 ng/ml mouse monoclonal H68.4 (13–6800)), Flotillin-1 (50 ng/ml). A, B: Triton X-100 extraction; C, D: Brij58 extraction; E, F: Brij97 extraction. B, D, F: Quantitation of the Western blots shown in panels A,C and E respectively using Advanced Image Data Analyzer (AIDA) software.

    Article Snippet: Goat polyclonal anti-CDCP1 (Ab1377) was from Abcam (Cambridge, U.K.).

    Techniques: Gradient Centrifugation, Western Blot, Quantitation Assay, Software

    Co-immunoprecipitation of CDCP1 and CD9. SW480 cells were lysed in 1% (w/v) Brij97, 10 mM Tris–HCl (pH 7.4), 150 mM NaCl, 1 mM CaCl 2 , 1 mM MgCl 2 . A. Immunoprecipitation from whole cell extracts of SW480 cells was performed using 5 μg of ALB6 anti-CD9 monoclonal antibody (lane 6) or isotype-matched control antibody (lane 5). Immunoprecipitates were analysed by Western blotting with antibodies against either CDCP1 (ab1377), top panel; EpCAM (ab32392), middle panel or CD9 (602.29), lower panel. Further controls for the specificity of immunoprecipitation and Western blotting are: lane 1: 15 μg whole cell extract, lanes 2 and 3: 5 μg of isotype-control antibody and anti-CD9 antibody respectively; lane 4: SW480 proteins bound to protein G beads. B. Densitometric analysis of the Western blot for CDCP1. A portion of the blot corresponding to the CDCP1 p135 region was analysed in the tracks generated by immunoprecipitation with the control (red) and anti-CD9 (green) antibodies using AIDA software.

    Journal: BMC Cancer

    Article Title: CUB Domain Containing Protein 1 (CDCP1) modulates adhesion and motility in colon cancer cells

    doi: 10.1186/1471-2407-14-754

    Figure Lengend Snippet: Co-immunoprecipitation of CDCP1 and CD9. SW480 cells were lysed in 1% (w/v) Brij97, 10 mM Tris–HCl (pH 7.4), 150 mM NaCl, 1 mM CaCl 2 , 1 mM MgCl 2 . A. Immunoprecipitation from whole cell extracts of SW480 cells was performed using 5 μg of ALB6 anti-CD9 monoclonal antibody (lane 6) or isotype-matched control antibody (lane 5). Immunoprecipitates were analysed by Western blotting with antibodies against either CDCP1 (ab1377), top panel; EpCAM (ab32392), middle panel or CD9 (602.29), lower panel. Further controls for the specificity of immunoprecipitation and Western blotting are: lane 1: 15 μg whole cell extract, lanes 2 and 3: 5 μg of isotype-control antibody and anti-CD9 antibody respectively; lane 4: SW480 proteins bound to protein G beads. B. Densitometric analysis of the Western blot for CDCP1. A portion of the blot corresponding to the CDCP1 p135 region was analysed in the tracks generated by immunoprecipitation with the control (red) and anti-CD9 (green) antibodies using AIDA software.

    Article Snippet: Goat polyclonal anti-CDCP1 (Ab1377) was from Abcam (Cambridge, U.K.).

    Techniques: Immunoprecipitation, Western Blot, Generated, Software